Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
29 Feb 2024 |
AA |
Micro company accounts made up to 31 January 2024
|
|
|
14 Aug 2023 |
AA |
Micro company accounts made up to 31 January 2023
|
|
|
13 May 2023 |
RESOLUTIONS |
Resolutions
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES13 ‐
Share transfer 21/04/2023
|
|
|
12 May 2023 |
PSC01 |
Notification of Pavel Nikonorov as a person with significant control on 21 April 2023
|
|
|
11 May 2023 |
PSC01 |
Notification of Stanislav Nikolskiy as a person with significant control on 21 April 2023
|
|
|
11 May 2023 |
PSC07 |
Cessation of Konstantin Stiskin as a person with significant control on 21 April 2023
|
|
|
11 May 2023 |
PSC07 |
Cessation of Kirill Petrenko as a person with significant control on 21 April 2023
|
|
|
28 Apr 2023 |
CS01 |
Confirmation statement made on 28 April 2023 with updates
|
|
|
28 Apr 2023 |
AP01 |
Appointment of Mr Stanislav Nikolskiy as a director on 21 April 2023
|
|
|
28 Sep 2022 |
CERTNM |
Company name changed genx global LIMITED\certificate issued on 28/09/22
-
NM01 ‐
Change of name by resolution
-
RES15 ‐
Change company name resolution on 2022-09-16
|
|
|
04 Jul 2022 |
AA |
Micro company accounts made up to 31 January 2022
|
|
|
29 Jun 2022 |
CS01 |
Confirmation statement made on 29 June 2022 with updates
|
|
|
29 Jun 2022 |
PSC01 |
Notification of Konstantin Stiskin as a person with significant control on 28 June 2022
|
|
|
01 Jun 2022 |
RESOLUTIONS |
Resolutions
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES10 ‐
Resolution of allotment of securities
|
|
|
25 May 2022 |
CS01 |
Confirmation statement made on 25 May 2022 with updates
|
|
|
25 May 2022 |
PSC07 |
Cessation of Vitalina Chamberlain-Evans as a person with significant control on 16 May 2022
|
|
|
25 May 2022 |
PSC01 |
Notification of Kirill Petrenko as a person with significant control on 16 May 2022
|
|
|
25 May 2022 |
SH01 |
Statement of capital following an allotment of shares on 16 May 2022
|
|
|
25 May 2022 |
TM01 |
Termination of appointment of Vitalina Chamberlain-Evans as a director on 9 May 2022
|
|
|
09 Nov 2021 |
AD01 |
Registered office address changed from 88 Lichfield Grove C/O Nccs Associates Limited London N3 2JN United Kingdom to Ab318, Biodata Innovation Centre Wellcome Genome Campus Hinxton Cambridgeshire CB10 1DR on 9 November 2021
|
|
|
29 Oct 2021 |
AA |
Micro company accounts made up to 31 January 2021
|
|
|
28 Oct 2021 |
CS01 |
Confirmation statement made on 28 October 2021 with updates
|
|
|
28 Oct 2021 |
PSC01 |
Notification of Vitalina Chamberlain-Evans as a person with significant control on 29 September 2021
|
|
|
13 Oct 2021 |
PSC07 |
Cessation of Konstantin Stiskin as a person with significant control on 29 September 2021
|
|
|
13 Oct 2021 |
PSC07 |
Cessation of Kirill Petrenko as a person with significant control on 29 September 2021
|
|